April 8, 2021

Meeting the Process Development Challenges of a Diverse Biologic Pipeline

Click here to learn more >>

In the current biopharmaceutical landscape, developers are constantly encountering new and diverse biological molecules with complex structures. While these novel biologics are filling drug pipelines, they are also challenging existing manufacturing processes in upstream, downstream, and analytical development.

Tags: Mabs, viral vectors, QbD, process development